3-186570920-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_016306.6(DNAJB11):c.23C>T(p.Thr8Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,604,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016306.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB11 | NM_016306.6 | c.23C>T | p.Thr8Ile | missense_variant | 1/10 | ENST00000265028.8 | NP_057390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB11 | ENST00000265028.8 | c.23C>T | p.Thr8Ile | missense_variant | 1/10 | 1 | NM_016306.6 | ENSP00000265028.3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152118Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000212 AC: 5AN: 236004Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 127840
GnomAD4 exome AF: 0.00000964 AC: 14AN: 1452460Hom.: 0 Cov.: 32 AF XY: 0.00000554 AC XY: 4AN XY: 722024
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152118Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.23C>T (p.T8I) alteration is located in exon 1 (coding exon 1) of the DNAJB11 gene. This alteration results from a C to T substitution at nucleotide position 23, causing the threonine (T) at amino acid position 8 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at